Important Safety Information: Certain patients should not use CERDELGA based on their CYP2D6 metabolizer status due to an increased risk of side effects, including heart problems. Do not use CERDELGA if you are an Extensive Metabolizer (EM) taking a medicine that is a strong or moderate CYP2D6 inhibitor along with another medicine that is a strong or... View more

Get Access

Understanding your insurance coverage is very important. Our CareConnectPSS® Case Managers are here to help you better understand your insurance benefits, so you can get access to the treatment you need.

Linda and Alan, USA,
patients with Gaucher disease type 1 treated with Cerdelga

Get access to the treatment you need. Sanofi Genzyme offers copay assistance and charitable access programs for eligible patients.

The CareConnectPSS Copay Program

The CareConnectPSS Copay Program helps eligible, US patients who are prescribed one of Sanofi Genzyme’s treatments pay for eligible, out-of-pocket, drug-related expenses, including copays, coinsurance, and deductibles.

The program is open to individuals who:

  • Have commercial insurance
  • Have prescription drug coverage
  • Are prescribed one of a Sanofi Genzyme treatment*
  • Are residents of the United States

The program is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), or other federal or state programs (including any state prescription drug assistance programs).


Complete an online enrollment application form. Your application will be reviewed for eligibility. If you are eligible, you will be automatically enrolled in the program. If eligible, you will receive your copay card within 7-10 days.

  • Contact your CareConnectPSS Case Manager if you do not receive this confirmation
  • Your doctor or specialty pharmacy will also receive a phone call with instructions on how to submit claims for reimbursement through the program
  • Your enrollment in the program is effective from the date of approval through the end of the calendar year (calendar year is January 1 through December 31)
  • For questions or to learn more about the program, call your CareConnectPSS Case Manager at this 1-800-745-4447, option 3.

    *The CareConnectPSS Copay Program is available only in the United States and cannot be combined with any other rebate/coupon, free trial, or similar offer. Copay benefits are not transferable. This program assists patients with their out-of-pocket drug costs for their prescribed Sanofi Genzyme treatment only and does not cover or provide support for the cost of MD office visits/evaluations, nursing services/observation periods, blood work, x-rays or other testing, premedications/other medications, EpiPens, transportation or other related services. No claim for reimbursement of any out-of-pocket expense covered by the CareConnectPSS Copay Program may be submitted to any third-party payer, where public or private. Sanofi Genzyme reserves the right to make eligibility decisions, set program maximums, and rescind, revoke, or amend this program without notice.

    Sanofi Genzyme Charitable Access Program

    This program was established in the US to provide Sanofi Genzyme’s therapies to eligible individuals who do not have health insurance or have inadequate coverage for treatment. It is considered a temporary solution until long-term coverage can be secured.

    The Sanofi Genzyme Charitable Access Program has been established in the United States through the Genzyme Charitable Foundation, Inc. The program is committed to providing Cerdelga to individuals who:

    • Medically need Cerdelga and
    • Are uninsured or have inadequate insurance coverage for Cerdelga

    Qualified individuals with Gaucher disease type 1 whose physicians have recommended treatment with Cerdelga may be eligible for the Charitable Access Program. If a patient is ineligible for our program, their CareConnectPSS Case Manager will work with the patient and their health care providers to explore alternative coverage options.

    To be considered for the program, you will be asked to provide the following:

    • A Letter of Intent to Treat with Cerdelga from your physician. The letter must be on MD letterhead and the physician must request charitable Cerdelga in the letter and reason why he/she is requesting charitable medication.
    • A Statement of Medical Necessity from your physician
    • A completed program application

    A CareConnectPSS Case Manager will coordinate with you and your physician to obtain the necessary documentation, including a signed waiver, and keep you updated on the status of your patient’s application. Applications are reviewed on a monthly basis and are kept confidential by the Sanofi Genzyme Charitable Access Program.

    Please note that the Sanofi Genzyme Charitable Access Program is considered a temporary program. Patients and their families are expected to continue exploring alternative resources with the assistance of a CareConnectPSS Case Manager. These may include:

    • Private insurance
    • Government programs

    To learn more about the Sanofi Genzyme Charitable Access Program or to request an application form, call 1-800-745-4447, Option 3.

    The Sanofi Genzyme Charitable Access Program may be discontinued at any time at the discretion of The Charitable Access Program Committee.


    Our CareConnectPSS
    team is here for you.

    Learn more

    learn more about

    Request Information